206. Fragile X syndrome
98 clinical trials,   73 drugs   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways

Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02998151
(ClinicalTrials.gov)
January 20161/12/2016Single-Dose Acamprosate, Lovastatin, Minocycline and Placebo in Fragile X SyndromeEvaluating the Neurophysiologic and Clinical Effects of Single-Dose Acamprosate, Lovastatin, Minocycline and Placebo in Fragile X SyndromeFragile X SyndromeDrug: Acamprosate;Drug: Lovastatin;Drug: Minocycline;Drug: PlaceboChildren's Hospital Medical Center, CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling by invitation15 Years55 YearsAll36Phase 2United States
2NCT01911455
(ClinicalTrials.gov)
June 201326/7/2013Study of Acamprosate in Fragile x SyndromeDouble-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X SyndromeFragile X SyndromeDrug: acamprosate;Drug: PlaceboChildren's Hospital Medical Center, CincinnatiRush University Medical CenterActive, not recruiting5 Years23 YearsAll48Phase 2;Phase 3United States
3NCT01300923
(ClinicalTrials.gov)
August 201025/8/2010Acamprosate in Youth With Fragile X SyndromePilot Study of Acamprosate in Youth With Fragile X SyndromeFragile X Syndrome;Autism Spectrum DisordersDrug: AcamprosateIndiana UniversityNULLCompleted5 Years17 YearsAll14Phase 2United States